DarioHealth Corp. (DRIO) analyst actions
Rating and price-target actions on DRIO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the DRIO overview →
1 measured DRIO analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose | Press release | +0.00% | -2.80% |
Keep exploring
More DRIO: earnings → · SEC filings → · DRIO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | 253 | -1.15% | 39% |
| Nevro Corp. (NVRO) | 253 | 0.00% | 49% |
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
| DOVA PHARMACEUTICALS (DOVA) | 251 | -0.10% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.